A generic screening study to establish structural and/or functional baselines of specific organs.
Male or female volunteers aged ≥18 to ≤80 years at the date of signing the informed consent.
Willingness and ability to provide written, personally signed, and dated informed consent, in accordance with the latest ICH Good Clinical Practice (GCP) Guidelines and applicable regulations.
An understanding, ability and willingness to fully comply with project procedures and restrictions.
GP diagnosis on HCF
Known alcoholic liver disease, history of cirrhosis of any other cause (metabolic, viral hepatitis or other)
Any other significant previous liver pathology (liver malignancy, portal hypertension, infiltrative liver disease)
Alcohol consumption >30 units per week
An Implanted cardiac devices
Richmond Research Institute
Lead sponsor
Richmond Pharmacology Limited
Collaborator